There has been major structural overhauls at the HHS. Credit: Douglas Rissing/ iStock via Getty Images. After sweeping cuts to US federal health agencies, the elimination of a committee responsible for recommending newborn screening regulations is raising alarms across the […]
Newborn screening strategy needs modernising as HHS disbands advisory committee Read More »
The two companies will co-develop precision RNA therapeutics for inherited hearing loss treatment. Credit: Scott Olson/Getty Images News via Getty Images. Eli Lilly is strengthening its position in genetic medicine for hearing loss through a new collaboration with South Korea-based
Eli Lilly strikes $1.3bn gene therapy deal with Rznomics Read More »
The FDA granted approval to both drugs on 14 May. Credit: Waldemarus/iStock via Getty Images. The US Food and Drug Administration (FDA) has approved two oncology drugs: MSD’s Welireg (belzutifan) and AbbVie’s Emrelis (telisotuzumab vedotin-tllv). The decisions, announced on 14
FDA awards cancer drug approvals to AbbVie and MSD Read More »
The deal with ADARx expands AbbVie’s siRNA focus. Image credit: hapabapa / iStock Editorial via Getty Images. AbbVie has signed a collaboration and licensing agreement with US-based ADARx Pharmaceuticals, committing $335m upfront to access its small interfering RNA (siRNA) platform.
AbbVie expands siRNA push with $335m ADARx deal Read More »
Novo Nordisk has entered a deal with Septerna for oral metabolic disorder drugs. Credit: [Victor Golmer]/[iStock Editorial/Getty Images Plus] via Getty Images. As competition continues to intensify in the obesity treatment market, Novo Nordisk has struck a collaboration and licencing
Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies Read More »
Stylus is developing an in vivo gene editing platform. Credit: Natali_Mis/iStock via Getty Images. Biotech startup Stylus Medicine has launched with $85m in funding to develop a new class of in vivo genetic medicines that bypass the manufacturing and delivery
Stylus Medicine launches with $85m to advance in vivo gene editing Read More »
President Trump held a press conference with the Secretary of Health and Human Services on 12 May. Credit: Andrew Harnik via Getty Images. US President Donald Trump has signed an executive order aimed at reducing prescription drug prices by linking
Pharma faces 30-day deadline under Trump’s pricing order Read More »
Roche’s planned facility in North Carolina will create 400 jobs. Credit: jetcityimage via Getty Images. Roche is deepening its manufacturing footprint in the US with plans to invest more than $700m in a new production facility in Holly Springs, North
Roche plans $700m manufacturing plant in the US Read More »
Trump has announced that he will sign a global drug price match policy. Credit: Anna Moneymaker via Getty Images. In a renewed push to overhaul pharmaceutical pricing in the US, President Donald Trump announced he will sign an executive order
Trump to sign order tying US drug prices to global rates Read More »
The venture firm 8VC led the Series B funding round to support Tempero, which is developing treatments for substance use disorders. Credit: Ekaterina Chizhevskaya via Getty Images. Tempero Bio has raised $70m in Series B financing to advance its lead
Tempero secures $70m to advance addiction treatment candidate Read More »
